About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- nortriptyline
- Procedure number
- PSUSA/00002192/202303
- Regulatory outcome
- Variation
Documents
Nortriptyline : List of nationally authorised medicinal products - PSUSA/00002192/202303
English (EN) (178.05 KB - PDF)
Nortriptyline : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00002192/202303
English (EN) (125.66 KB - PDF)
български (BG) (157.09 KB - PDF)
español (ES) (115.56 KB - PDF)
čeština (CS) (146.06 KB - PDF)
dansk (DA) (116.16 KB - PDF)
Deutsch (DE) (119 KB - PDF)
eesti keel (ET) (113.81 KB - PDF)
ελληνικά (EL) (158.8 KB - PDF)
français (FR) (147.07 KB - PDF)
hrvatski (HR) (154.19 KB - PDF)
íslenska (IS) (106.84 KB - PDF)
italiano (IT) (128.03 KB - PDF)
latviešu valoda (LV) (141.54 KB - PDF)
lietuvių kalba (LT) (134.51 KB - PDF)
magyar (HU) (142.03 KB - PDF)
Malti (MT) (163.28 KB - PDF)
Nederlands (NL) (117.74 KB - PDF)
norsk (NO) (114.76 KB - PDF)
polski (PL) (145.86 KB - PDF)
português (PT) (115.82 KB - PDF)
română (RO) (133.89 KB - PDF)
slovenčina (SK) (136.05 KB - PDF)
slovenščina (SL) (128.97 KB - PDF)
Suomi (FI) (113.55 KB - PDF)
svenska (SV) (115.9 KB - PDF)